4-Hydroxyamphetamine
4-Hydroxyamphetamine (4-HA), also known as para-hydroxyamphetamine (PHA), is a psychoactive drug and research chemical belonging to the phenethylamine and amphetamine chemical classes. It acts primarily as a norepinephrine-dopamine releasing agent (NDRA) with psychoactive and stimulant properties. This compound is related to more commonly known substances such as amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA).
Pharmacology[edit]
4-Hydroxyamphetamine has a mechanism of action similar to other amphetamine derivatives. It works by increasing the release of neurotransmitters such as dopamine and norepinephrine in the brain, leading to stimulant effects. Additionally, 4-HA may act as a serotonin releasing agent to a lesser extent. The compound's ability to release norepinephrine and dopamine contributes to its use in scientific research to study the neurotransmitter system and potential therapeutic applications.
Medical Use[edit]
Historically, 4-Hydroxyamphetamine has been used in the form of its hydrobromide salt as a mydriatic (to dilate the pupils) and in diagnostic procedures related to the sympathetic nervous system. However, its use in clinical settings has declined due to the development of more selective agents with fewer side effects.
Legal Status[edit]
The legal status of 4-Hydroxyamphetamine varies by country, but it is often regulated due to its structural similarity to controlled substances such as amphetamine and methamphetamine. In many jurisdictions, its manufacture, possession, and distribution are restricted or banned outright.
Research[edit]
Research on 4-Hydroxyamphetamine has focused on its potential applications in neuroscience and pharmacology, particularly its effects on the neurotransmitter system. Studies have explored its use as a tool to investigate the mechanisms of neurotransmitter release and reuptake, as well as its potential therapeutic effects in treating neurological disorders. However, due to its psychoactive properties and regulatory status, research is often limited.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
